Medication is sometimes necessary to treat eye conditions and vision problems. Of course, this is highly dependent on the ...

The company says preclinical trials demonstrate its signature molecule can help prevent cell damage that can lead to ...

Pegcetacoplan (Syfovre) is now approved in Australia for treating geographic atrophy (GA) secondary to age-related macular ...

HDL cholesterol levels demonstrate a U-shaped association with AMD, in which both high and low levels elevate risk.

WALTHAM, Mass. - Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a $3.7 billion market cap biotech company showing impressive revenue growth of 162% over the last twelve months, today announced that the ...

About SYFOVRE® (pegcetacoplan injection) SYFOVRE ® (pegcetacoplan injection) is the first-ever approved therapy for geographic atrophy (GA). By targeting C3, SYFOVRE is designed to provide ...

Pharmaceuticals announced that the Therapeutic Goods Administration, TGA, has approved SYFOVRE or pegcetacoplan, for the ...

In this Healio Video Perspective from Retina 2025, Mark Gillies, MD, PhD, of the Save Sight Institute in Sydney, Australia, discusses positive safety and efficacy data for NT-501 for macular ...

SolidddVision Smartglasses mimic a fly's eye structure to fill in missing vision for macular degeneration sufferers.

There are lots of interesting companies that make Bedford their home. Here is a quick recap of what’s happening around town ...

Study from Case Western Reserve University and VA Northeast Ohio Healthcare System examines genetic risk profiles across ...

At a single academic tertiary referral center, mild intraocular inflammation developed in four eyes following intravitreal ...